Reliable and sensitive determination of dutasteride in human plasma by liquid chromatography-tandem mass spectrometry

ABSTRACT An accurate and precise method was developed and validated using LC‐MS/MS to quantify dutasteride in human plasma. The analyte and dutasteride‐13C6 as internal standard (IS) were extracted from 300 μL plasma volume using methyl tert‐butyl ether–n‐hexane (80:20, v/v). Chromatographic analysi...

Full description

Saved in:
Bibliographic Details
Published inBiomedical chromatography Vol. 27; no. 9; pp. 1168 - 1176
Main Authors Contractor, Pritesh, Kurani, Hemal, Guttikar, Swati, Shrivastav, Pranav S.
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.09.2013
Subjects
Online AccessGet full text
ISSN0269-3879
1099-0801
1099-0801
DOI10.1002/bmc.2923

Cover

More Information
Summary:ABSTRACT An accurate and precise method was developed and validated using LC‐MS/MS to quantify dutasteride in human plasma. The analyte and dutasteride‐13C6 as internal standard (IS) were extracted from 300 μL plasma volume using methyl tert‐butyl ether–n‐hexane (80:20, v/v). Chromatographic analysis was performed on a Gemini C18 (150 × 4.6 mm, 5 µm) column using acetonitrile–5 mm ammonium formate, pH adjusted to 4.0 with formic acid (85:15, v/v) as the mobile phase. Tandem mass spectrometry in positive ionization mode was used to quantify dutasteride by multiple reaction monitoring. The entire data processing was done using Watson LIMSTM software, which provided excellent data integrity and high throughput with improved operational efficiency. The calibration curve was linear in the range of 0.1–25 ng/mL, with intra‐and inter‐batch values for accuracy and precision (coefficient of variation) ranging from 95.8 to 104.0 and from 0.7 to 5.3%, respectively. The mean overall recovery across quality controls was ≥95% for the analyte and IS, while the interference of matrix expressed as IS‐normalized matrix factors ranged from 1.01 to 1.02. The method was successfully applied to support a bioequivalence study of 0.5 mg dutasteride capsules in 24 healthy subjects. Assay reproducibility was demonstrated by reanalysis of 103 incurred samples. Copyright © 2013 John Wiley & Sons, Ltd.
Bibliography:ark:/67375/WNG-C7PX9G3G-G
istex:39A65E464A9FCAC433499A25F64EEF82944479D1
ArticleID:BMC2923
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0269-3879
1099-0801
1099-0801
DOI:10.1002/bmc.2923